The current status of mild cognitive impairment—what do we tell our patients?
Ronald C Petersen
Correspondence Department of Neurology, Mayo Alzheimer's Disease Research Center, Mayo Clinic College of Medicine, 200 First Street South West, Rochester, MN 55905, USA
Email peter8@mayo.edu
Ronald Petersen developed the concept of mild cognitive impairment (MCI) in the late 1990s. The concept has since been expanded to include several subtypes, with amnestic MCI being recognized as a risk state for Alzheimer's disease. This Viewpoint highlights the benefits of retaining the MCI classification, both from a research and from a clinical point of view.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
